- OptimizeRX acquires RMDY Health, a multipurpose digital therapeutics SaaS platform, for $16 million in cash and equity.
- Acquisition will enhance OptimizeRx existing digital platform with technology solutions tailored for digital therapeutics and extends offerings to SaaS-based patient engagement markets.
- RMDY will maintain its technology team in Tel Aviv, Israel, and U.S. based personnel and use the OptimizeRx New Jersey HQ.
OptimizeRx announced it will acquire RMDY
Read More
Digital Therapeutics | Digital Health | Evidence-Based Therapeutics Interventions
4th Annual Accenture HealthTech Innovation Challenge Kicks Off
Quick Glance- Accenture kicks off the application period for the fourth annual Accenture HealthTech Innovation Challenge- Challenge seeks to support innovative approaches and solutions for improving the way people access, manage and finance healthcare in North America- Three categories for this year’s Accenture HealthTech Innovation Challenge are operational efficiency, increased access, and consumer experienceAccenture, today kicked off the application period for the fourth annual
Read More
HLTH & ATA Partner Up to Highlight Telehealth Solutions, Virtual Care Adoption
HLTH, the largest and most important conference for healthcare innovation announced a new partnership with ATA, the premier organization working to accelerate the adoption of telehealth, to showcase innovations in virtual care that will change the way care is ultimately delivered.Telehealth solutions include digital health, artificial intelligence (AI), virtual care, remote monitoring, and digital therapeutics (DTx), as well as 'store-and-forward' or asynchronous technologies that securely
Read More
Progentec Diagnostics Merges with Karate Health to Expand Autoimmune Disease Management Platforms
Karate Health merges with Progentec to pursue comprehensive disease management solutions for lupus and multiple sclerosis (MS) that combine laboratory testing with digital technologies. Progentec Diagnostics, Inc. and Karate Health, Inc. announced that they have merged, offering laboratory testing and digital technologies for the diagnosis and management of lupus (SLE), multiple sclerosis (MS), and other autoimmune diseases. The merger is a substantive step towards the Progentec mission of
Read More
Yale, Mayo Clinic, Biofourmis Launches Research to Detect Heart Failure Using Wearable Biosensor Data
Biofourmis has entered a research partnership with the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI). Biofourmis' mobile platform BiovitalsHFTM will be leveraged in a study of patients with heart failure to monitor functional capacity and quality of life to see if greater emphasis should be placed on these measures in the drug approval process.Impact of Heart FailureHeart failure afflicts approximately 6.5 million patients in the United States and
Read More
Blue Shield of California Launches Digital Therapeutics Platform At No Cost to Members
Blue Shield of California is launching a new digital therapeutics platform that will provide programs to eligible members at no cost to them. Powered by Solera Health, the new Wellvolution platform provides curated, scientific and results-based digital programs that can be personalized to each of its members' individual health needs and preferences. The program is available at no cost to members enrolled in Blue Shield's fully insured employer-sponsored plans or it's Individual and Family
Read More
Cara Care Nabs $7M to Expand Digital Therapuetic App for Digestive Diseases
Berlin, Germany-based digital health company Cara Care, announced today that it has secured $7 million in Series A funding led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Barcelona-based VC firm Asabys Partners with participation from existing investor Atlantic Labs. Cara Care was part of the Microsoft Accelerator and winner of the GlaxoSmithKline Transforming the Future of Self-Care Challenge in the category “Digital Health Technologies.” Cara Care has raised more than $9
Read More
Cleveland Clinic Study: Propeller Health’s Smart Inhalers Reduces Hospitalizations, ER Visits for COPD Patients
Cleveland Clinic today released research that uses Propeller Health’s smart inhaler platform to show that digital medicines significantly reduced hospital visits for COPD patients. COPD is a term applied to a family of diseases that includes emphysema, chronic bronchitis, and emphysema due to alpha-1 antitrypsin deficiency. The research findings published in The Journal of Telemedicine and Telecare marks the first-ever research to assess the impact of a digital medicine on healthcare utilization
Read More
NightWare Awarded FDA “Breakthrough Status” for PTSD Apple Watch App
NightWare, Inc., digital therapeutics for mental health company has received Breakthrough Status designation from the U.S. Food and Drug Administration (FDA) for its NightWare Apple Watch app that measures and treats nightmares in people with Post-Traumatic Stress Disorder (PTSD).Impact of Nightmare DisordersNightmares and Nightmare Disorder have been linked to increased suicidality, heightened risk of heart disease, diabetes, and contributes to cognitive difficulties such as memory loss,
Read More
Biofourmis Lands $35M for AI-Powered Digital Therapeutics Platform
Biofourmis, a Boston, MA-based digital therapeutics platform, today announced that it has raised $35 million in Series B funding led by Sequoia Capital/Sequoia India and co-led by Mass Mutual. The latest funding round will enable the company to advance its proprietary artificialintelligence (AI)-powered digital therapeutics platform and pipeline that treats and manages a range of complex chronic conditions.Digital Therapeutics is Redefining The Healthcare Value ChainFounded in 2015, Biofourmis
Read More